From CBS News · · 1m 10s
Eli Lilly's unapproved weight loss drug sold illegally online
Retatrutide, still in clinical trials, is being marketed and sold to Americans through unauthorized online channels.
In brief
Retatrutide, still in clinical trials, is being marketed and sold to Americans through unauthorized online channels. An experimental weight loss drug not yet approved for use is being illegally sold online to U.S. customers, posing unknown safety risks. Originally reported by CBS News.
Experimental drug sold illegally online
Retatrutide, an Eli Lilly weight loss drug still in clinical trials, is being marketed and sold to U.S. customers through unauthorized online channels, according to a CBS News investigation.
Drug remains in testing phase
Retatrutide has not completed clinical trials or received FDA approval for any use. It is still being tested by Eli Lilly to determine its safety and effectiveness.
Unknown risks to consumers
Buying an unapproved experimental drug online means consumers have no guarantee of safety, purity, or proper dosing. The drug's long-term effects remain unknown.
Illegal marketplace thriving
Multiple companies are operating online to sell Retatrutide to U.S. customers without authorization, suggesting a growing black market for weight loss drugs.
Regulatory enforcement gap
The illegal sales highlight challenges in monitoring and stopping unauthorized drug distribution online, even for drugs that haven't been approved for public use.
The big picture
An experimental weight loss drug not yet approved for use is being illegally sold online to U.S. customers, posing unknown safety risks.
